AGM/EGMJul 24, 2026, 05:06 PM
NovaBridge Biosciences to Hold AGM on Sep 8; Proposes Director Removal
AI Summary
NovaBridge Biosciences announced it will hold its Annual General Meeting (AGM) on September 8, 2026, at its Shanghai office. Shareholders of record as of July 27, 2026, are eligible to vote. A key resolution to be submitted for shareholder approval is the removal of Ms. Xin Liu from her position as a director, which the Board recommends voting "FOR" to enhance corporate governance and operational efficiency. The company's Annual Report on Form 20-F for the fiscal year ended December 31, 2025, is also available.
Key Highlights
- Annual General Meeting (AGM) scheduled for September 8, 2026, at 10:00 a.m. Shanghai time.
- AGM to be held at NovaBridge Biosciences Shanghai office.
- Shareholders of record as of July 27, 2026 (Shanghai time) are entitled to vote.
- ADS holders of record as of July 27, 2026 (New York time) can exercise voting rights through Citibank, N.A.
- Voting instructions for ADSs must be received by September 1, 2026, 10:00 a.m. Eastern Time.
- Shareholders will vote on the removal of Ms. Xin Liu as a director.
- The Board recommends shareholders vote "FOR" the resolution to remove Ms. Xin Liu.
- Company's Annual Report on Form 20-F for fiscal year ended December 31, 2025, is available.
Price Impact
More from NBP